Beckman Coulter Augments Genomic Services with Cogenics Acquisition

$17 million. Beckman will acquire all of Cogenics' operations in the US, UK, France, and Germany.

Cogenics provides genomics services, such as DNA sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction, and biobanking. Its services will complement those of Beckman's Agencourt Biosciences (Beverly, MA, USA) business, which also offers genomics services and nucleic acid purification products.

Agencourt and Cogenics customers will receive a broad range of genomic services including sample preparation, genotyping, gene expression, biologics efficacy and safety testing, as well as comprehensive sequencing service offerings. Initially customers should contact the respective business where their work is being performed. The companies will strive to ensure that there will be minimal disruption to any ongoing projects in progress with either Agencourt or Cogenics.

Beckman Coulter is a leader in biomedical testing and the merged company will be positioned as a leading provider of genomic services. The business headquarters will be located in Beverly (MA, USA). As such, it will enable discovery, detection, and diagnostics to improve human health, in keeping with Beckman Coulter's mission.

Related Links:
Beckman Coulter
Cogenics
Agencourt Biosciences